GM21654
LCL from B-Lymphocyte
Description:
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2
CENTROSOMAL PROTEIN, 57-KD; CEP57
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Chromosome Abnormalities |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Ethnicity
|
Hispanic/Latino
|
Ethnicity
|
MEXICAN
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Karyotypic analysis before cell line submission to CCR
|
ISCN
|
45-50,XY,+X[2],-Y[1],-2[1],-5[1],+5[2],+6[1],+7[1],+9[1],+13[1],+14[2],+15[2],+21[1],+22[1],+mar[1][cp50]
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
|
Gene |
CEP57 |
Chromosomal Location |
11q21 |
Allelic Variant 1 |
607951.0001; MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2 |
Identified Mutation |
c.520_521del (p.Glu174fs) |
|
Gene |
CEP57 |
Chromosomal Location |
11q21 |
Allelic Variant 2 |
607951.0002; MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2 |
Identified Mutation |
c.915_925dup (p.Leu309fs) |
Remarks |
Laringeal stridor without respiratory distress was noted at birth; laryngoscopy revealed a laryngeal cyst; hypothyroidism diagnosed at age 6 months; dolichocephaly; prominent occiput; frontal bossing; triangular face; inverted epicanthic folds; small nose; micrognathia; low-set ears; cafe au lait spot of 8 cm diameter in left pectoral region with irregular borders; clinodactyly of hands; cranial CAT scan, eyes, abdomen and genitalia are normal; no evidence of malignancy; affected sister is GM21655; molecular analysis showed no BUB1B mutation |
Watanabe K, Takao D, Ito KK, Takahashi M, Kitagawa D, The Cep57-pericentrin module organizes PCM expansion and centriole engagement Nature communications10:931 2017 |
PubMed ID: 30804344 |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|